Maiwald at the LSPN North America Spring 2025 in Boston, May 6-7, 2025

Maiwald is joining one of the most influential IP conference in the life sciences

The annual Life Sciences Patent Network (LSPN) Spring Conference in North America is an important meeting place for gaining innovative insights into the challenges of intellectual property in the pharmaceutical, biotechnology, and medical device industries.

We are delighted to have been a gold sponsor of the 2025 Life Sciences Patent Network North America Spring Conference — a unique opportunity to network and gain valuable insights into the latest trends, challenges, and best practices that are shaping the future of innovation in the life sciences.

One highlight was the panel discussion with Dr. Eva Ehlich, titled “The Transparency Tightrope: Balancing Innovation, Regulation, and IP Protection in a New Era.” The discussion covered the far-reaching consequences of increased transparency requirements for clinical trials and their impact on the global patent system. Recent regulatory changes in clinical trials and their effect on patent applications and rights were also discussed.

Dr. Eva Ehlich, Dr. Anja Fux, and Dr. Sun Jin Lee were pleased with the exciting exchange and new insights gained.